William Bartlow
Family Medicine · Pennsdale, PANPI 1881690501
Payments from drug & device makers
Across 106 payments — averaging $19.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$314
- Lilly USA, LLC$230
- Novo Nordisk$170
- Exact Sciences$155
- Tandem Diabetes Care, Inc.$112
- Boehringer Ingelheim$89
- plus $954 from 23 others
What the payments were for
- Food & beverage$2,024100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 14 | $314 |
| Lilly USA, LLC | 12 | $230 |
| Novo Nordisk | 9 | $170 |
| Exact Sciences | 6 | $155 |
| Tandem Diabetes Care, Inc. | 4 | $112 |
| Boehringer Ingelheim | 6 | $89 |
| GSK | 6 | $89 |
| Indivior Inc. | 4 | $87 |
| Daiichi Sankyo Inc. | 4 | $82 |
| AstraZeneca | 5 | $75 |
| Kyowa Kirin, Inc. | 4 | $75 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $55 |
| Shield Therapeutics Inc | 3 | $49 |
| Abbott | 3 | $48 |
| Ultragenyx Pharmaceutical Inc. | 2 | $47 |
| Dexcom, Inc. | 2 | $46 |
| Novartis | 3 | $44 |
| Amgen | 2 | $40 |
| Merck | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
| Alkermes, Inc. | 1 | $25 |
| Pfizer | 2 | $22 |
| Astellas Pharma US Inc | 1 | $20 |
| Johnson & Johnson | 1 | $18 |
| Therapeuticsmd, Inc. | 1 | $16 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
| Philips North America LLC | 1 | $14 |
| Hologic Sales And Service, LLC | 1 | $14 |
| Shire North American Group Inc | 1 | $13 |
How this compares
$2,024 in reported general payments places this provider in the 75th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 211 | $155,181 |
| JardianceEmpagliflozin | 85 | $80,415 |
| XareltoRivaroxaban | 62 | $60,883 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 64 | $47,630 |
| OzempicSemaglutide | 51 | $47,114 |
| TrulicityDulaglutide | 40 | $43,450 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 45 | $19,907 |
| FarxigaDapagliflozin Propanediol | 18 | $14,731 |
| Breo ElliptaFluticasone/Vilanterol | 18 | $12,095 |
| JanuviaSitagliptin Phosphate | 14 | $11,640 |
| Advair HfaFluticasone Propion/Salmeterol | 26 | $10,243 |
| TradjentaLinagliptin | 15 | $7,596 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 245 | $7,027 |
| JentaduetoLinagliptin/Metformin Hcl | 13 | $5,835 |
| Atorvastatin Calcium | 473 | $5,356 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $22 | $155,181211 claims |
| Boehringer IngelheimJardiance, Tradjenta, Jentadueto, Stiolto Respimat | $89 | $98,894124 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $89 | $79,632127 claims |
| Johnson & JohnsonXarelto | $18 | $60,88362 claims |
| Novo NordiskOzempic | $170 | $47,11451 claims |
| Lilly USA, LLCTrulicity | $230 | $43,45040 claims |
| AstraZenecaFarxiga | $75 | $14,73118 claims |
| MerckJanuvia | $30 | $11,64014 claims |
| Astellas Pharma US IncMyrbetriq | $20 | $4,90212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Pennsdale
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
- Bruce GebhardtErie$2.1M
- Peter CognettiScranton$1.9M
- Bradley FoxErie$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.